Thursday 7th May 2020
On April 16th we released a statement which mapped out our response to the impact of the Covid-19 outbreak on cardiovascular disease, and we believe that now is the right time for us to begin to look forward and map a strategic direction for the next phase of our response.
Thursday 16th April 2020
The global COVID-19 crisis has put an enormous strain on the UK health system which faces the battle of limiting the spread of Coronavirus whilst also providing the treatment and care that will save lives. As a result of this, the UK healthcare system is having to change the way it works and what they prioritise, impacting patients presenting with many conditions, including heart valve disease.
Wednesday 4th March 2020
Last Tuesday’s Westminster Forum focussed on the next steps in prevention, innovation and delivery of care for cardiovascular disease.
Wednesday 29th January 2020
We are are pleased to see valve disease research identified in the Top 10 research priorities compiled by Heart Surgery Priority Setting Partnership at the University of Leicester Medical School.
Friday 17th January 2020
Hull University Teaching Hospital NHS Trust had its first year of administrating TAVI to patients in the region of Hull and East Yorkshire. Mr David Morris, 86, received the first TAVI in March of 2019 under Dr Raj Chelliah, Consultant Cardiologist, and his team.
Wednesday 9th October 2019
Professor Jan Kovac, an interventional cardiologist at Glenfield Hospital in Leicester, presented a live Transcatheter aortic valve implantation procedure (TAVI) on the 9th of October. As part of the International Structural Heart Disease conference.
Thursday 19th September 2019
We're proud to be launching our report ‘State of the Nation: Heart Valve Disease in Wales’ today during European Heart Valve Disease Awareness Week. The new report sets outs recommendations for early diagnosis and treatment services in Wales.